Remedy Robotics is a medical technology company based in San Francisco that develops robotic systems for endovascular intervention. Its work focuses on the intersection of robotics, machine learning, and advanced computer vision, applied to neurovascular and broader endovascular procedures.
The company's principal product is the Remedy N1 System, described as the world's first remotely operable endovascular surgical robotic platform. It is designed to integrate with existing catheterization laboratory infrastructure and incorporates AI-enabled software. The platform has been used in a series of procedural firsts, including completely robotic neurointerventional procedures in humans from start to finish, completely remote robotic neurointerventional procedures, and autonomous endovascular navigation.
Remedy Robotics brings together clinicians and engineers to address challenges in endovascular care. Its technical teams work across robotics, machine learning, and computer vision to develop systems intended to advance the precision and accessibility of vascular intervention.
